{
    "2019-09-09": [
        [
            {
                "time": "",
                "original_text": "【东兴医药胡博新团队】“不一样的财报解读”系列之2019年中报：新赛道新增量，大蓝海市场水深船阔",
                "features": {
                    "keywords": [
                        "东兴医药",
                        "财报解读",
                        "2019年中报",
                        "新赛道",
                        "新增量",
                        "大蓝海市场"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报: 病理免疫组化为被市场遗忘的“小化学发光”",
                "features": {
                    "keywords": [
                        "医药行业",
                        "周报",
                        "病理免疫组化",
                        "小化学发光"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}